Sec. 9701.
As used in this part:
(a) “Committee” means the Michigan pharmacy and therapeutics committee established by Executive Order No. 2001-8 and by section 9705.
(b) “Controlled substance” means that term as defined in section 7104.
(c) “Department” means the department of community health.
(d) “Drug” means that term as defined in section 17703.
(e) “Initiative” means the pharmaceutical best practices initiative established by this part.
(f) “Medicaid” means the program of medical assistance established under title XIX of the social security act, 42 USC 1396 to 1396v.
(g) “Pharmacist” means an individual licensed by this state to engage in the practice of pharmacy under article 15.
(h) “Physician” means an individual licensed by this state to engage in the practice of medicine or osteopathic medicine and surgery under article 15.
(i) “Prescriber” means a licensed dentist, a licensed doctor of medicine, a licensed doctor of osteopathic medicine and surgery, a licensed doctor of podiatric medicine and surgery, a licensed optometrist certified under part 174 to administer and prescribe therapeutic pharmaceutical agents, or another licensed health professional acting under the delegation and using, recording, or otherwise indicating the name of the delegating licensed doctor of medicine or licensed doctor of osteopathic medicine and surgery.
(j) “Prescription” means that term as defined in section 17708.
(k) “Prescription drug” means that term as defined in section 17708.
(l) “Type II transfer” means that term as defined in section 3 of the executive organization act of 1965, 1965 PA 380, MCL 16.103.
History: Add. 2004, Act 250, Imd. Eff. July 23, 2004
Popular Name: Act 368
Last modified: October 10, 2016